rs1555408829
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM2PP2PP3_ModeratePP5_Very_Strong
The NM_001376.5(DYNC1H1):c.3278T>C(p.Phe1093Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001376.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 13 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1461888Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 727244
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
The c.3278T>C (p.F1093S) alteration is located in exon 13 (coding exon 13) of the DYNC1H1 gene. This alteration results from a T to C substitution at nucleotide position 3278, causing the phenylalanine (F) at amino acid position 1093 to be replaced by a serine (S). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This variant was determined to be de novo in at least one individual with features consistent with DYNC1H1-related neurologic disorders (Helbig, 2016; Yang, 2021). This amino acid position is highly conserved in available vertebrate species. The p.F1093S amino acid is located within the stem domain (amino acids 53-1867), in the region responsible for DYNC1H1 dimerization (300-1140) (Willemsen, 2012). This alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, this alteration is classified as pathogenic. -
not provided Pathogenic:1
Not observed in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 26795593) -
DYNC1H1-related disorder Pathogenic:1
The DYNC1H1 c.3278T>C variant is predicted to result in the amino acid substitution p.Phe1093Ser. This variant has been reported as a de novo variant in patients with epileptic encephalopathy and infantile spasms (Helbig et al. 2016. PubMed ID: 26795593). This variant was also interpreted as pathogenic in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/449962/). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. This variant is interpreted as likely pathogenic. -
Spinal muscular atrophy with lower extremity predominance;C3280220:Charcot-Marie-Tooth disease axonal type 2O;C3281202:Intellectual disability, autosomal dominant 13 Other:1
Variant interpreted as Pathogenic and reported on 08-21-2017 by Lab or GTR ID 26957. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at